Minichmayr, Iris K. http://orcid.org/0000-0002-2679-8589
Wicha, Sebastian G. http://orcid.org/0000-0002-8773-4845
Matzneller, Peter
Kloft, Charlotte
Zeitlinger, Markus http://orcid.org/0000-0002-1873-3953
Funding for this research was provided by:
Medical University of Vienna
Article History
Accepted: 30 October 2023
First Online: 26 November 2023
Declarations
:
: Open access funding provided by Medical University of Vienna.
: Charlotte Kloft reports grants from an industry consortium (AbbVie Deutschland GmbH & Co. KG, Astra-Zeneca, Boehringer Ingelheim Pharma GmbH & Co. KG, Grünenthal GmbH, F. Hoffmann-La Roche Ltd, Merck KGaA and SANOFI), the Innovative Medicines Initiative-Joint Undertaking (‘DDMoRe’), Diurnal Ltd, the Federal Ministry of Education and Research within the Joint Programming Initiative on Antimicrobial Resistance Initiative (JPIAMR), and the European Commission within the Horizon 2020 framework programme (‘FAIR’). Markus Zeitlinger’s institution received various grants from Pfizer for different research purposes but none were associated with the present work. Iris K. Minichmayr, Sebastian G. Wicha, and Peter Matzneller have no conflicts of interest to declare.
: Data are presented in the manuscript. The datasets generated and/or analysed during the current study are available from the study centre on reasonable request.
: This study was conducted at the Medical University of Vienna in accordance with ICH-GCP guidelines and the Declaration of Helsinki after approval by the Institutional Ethics Committee (1930/2012) and Institutional Review Board (see also the Methods section).
: This study was conducted after signed informed consent was received from all study subjects (see also the Methods section).
: Not applicable.
: The control stream used for the current analysis is available from the corresponding author on reasonable request.
: IKM: conceptualisation of the analysis, data analyses, interpretation of the results, drafting of the manuscript. SGW: methodology, interpretation of the results, critical revision of the manuscript. PM: data acquisition, critical revision of the manuscript. CK: interpretation of the results, supervision, critical revision of the manuscript. MZ: data acquisition, supervision, critical revision of the manuscript. All authors approved the final version of the manuscript.